UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 93 filers reported holding UROGEN PHARMA LTD in Q3 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,069,969 | +47.0% | 219,127 | +8.6% | 0.00% | – |
| Q2 2023 | $2,087,812 | +1471.7% | 201,721 | +1303.2% | 0.00% | – |
| Q1 2023 | $132,834 | +104493.7% | 14,376 | 0.0% | 0.00% | – |
| Q4 2022 | $127 | -99.9% | 14,376 | 0.0% | 0.00% | – |
| Q3 2022 | $119,000 | +1.7% | 14,376 | 0.0% | 0.00% | – |
| Q2 2022 | $117,000 | -92.4% | 14,376 | -91.8% | 0.00% | – |
| Q1 2022 | $1,534,000 | -3.8% | 176,213 | +5.0% | 0.00% | – |
| Q4 2021 | $1,595,000 | -38.5% | 167,757 | +8.8% | 0.00% | – |
| Q3 2021 | $2,593,000 | +2.6% | 154,185 | -6.9% | 0.00% | – |
| Q2 2021 | $2,528,000 | -21.4% | 165,595 | +0.3% | 0.00% | – |
| Q1 2021 | $3,217,000 | +21.8% | 165,165 | +12.6% | 0.00% | – |
| Q4 2020 | $2,642,000 | -7.8% | 146,642 | -1.3% | 0.00% | -100.0% |
| Q3 2020 | $2,866,000 | -26.3% | 148,605 | -0.2% | 0.00% | 0.0% |
| Q2 2020 | $3,889,000 | +58.5% | 148,917 | +8.2% | 0.00% | 0.0% |
| Q1 2020 | $2,454,000 | -70.0% | 137,585 | -43.9% | 0.00% | 0.0% |
| Q4 2019 | $8,178,000 | +212.7% | 245,088 | +123.3% | 0.00% | 0.0% |
| Q3 2019 | $2,615,000 | -30.1% | 109,764 | +5.5% | 0.00% | 0.0% |
| Q2 2019 | $3,739,000 | +550.3% | 104,050 | +568.1% | 0.00% | – |
| Q1 2019 | $575,000 | -17.6% | 15,575 | -4.2% | 0.00% | – |
| Q4 2018 | $698,000 | +82.2% | 16,250 | +100.0% | 0.00% | – |
| Q3 2018 | $383,000 | +7.9% | 8,125 | +13.7% | 0.00% | – |
| Q2 2018 | $355,000 | 0.0% | 7,145 | 0.0% | 0.00% | – |
| Q1 2018 | $355,000 | +34.0% | 7,145 | 0.0% | 0.00% | – |
| Q4 2017 | $265,000 | +17.8% | 7,145 | 0.0% | 0.00% | – |
| Q3 2017 | $225,000 | – | 7,145 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,620,545 | $36,713,835 | 6.69% |
| Wildcat Capital Management, LLC | 495,606 | $6,943,440 | 2.79% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 508,883 | $7,129,451 | 2.16% |
| Opaleye Management Inc. | 320,000 | $4,483,200 | 1.46% |
| AlphaCentric Advisors LLC | 165,000 | $2,311,650 | 1.31% |
| Soleus Capital Management, L.P. | 372,000 | $5,211,720 | 0.48% |
| EAM Investors, LLC | 170,523 | $2,389,027 | 0.46% |
| RA Capital Management | 1,483,697 | $20,786,595 | 0.41% |
| Parkman Healthcare Partners LLC | 145,311 | $2,035,807 | 0.37% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,303,031 | $32,265,464 | 0.29% |